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Vilsmeier reactionAbstract Biheterocyclic compounds in recent years have gained a signiﬁcant importance in medic-
inal chemistry. In this paper the synthesis of novel pyrazol-3ylthiazoles through Vilsmeier–Haack
reaction using 2-amino thiazoles as precursors is described. Synthesis of twelve new derivatives
was accomplished with moderate yield (70–76%). Structures of all the newly synthesized com-
pounds were characterized by spectral (1H NMR, 13C NMR, IR, LC–MS) and elemental analyses.
ª 2014 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is
an open access article under the CCBY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
In the area of heterocyclic chemistry a recent trend has been
the revival of interest in biheterocyclic systems. The current
interest in these systems may be attributed to their presence
as structural units in a variety of highly bioactive terrestrial
and marine natural products. It has been recognized that a
suitably structured ligand may bind by occupying two or more
sites, multivalent, on the biomolecules. This concept has been a
new trend in drug research and has been reviewed (Wright and
Usher, 2001). Biheterocyclic compounds have also stimulated
a keen interest among material chemists, who have been study-
ing polythiophenes and polypyrroles as conducting polymers
and oligoheterocycles as molecular wires as well as dyes
(Park et al., 2001) with novel optical properties. Biheterocycles
having luminescent properties have also been reported (Noack
et al., 2002). Some of the biheterocyclic compounds arereported to have much better antibacterial activity when com-
pared to that of monoanalogues (Zhang et al., 1991). Bihetero-
cyclic compounds also can act as a powerful chelating agent,
forming stable coordination polymers, complexes with various
transition metals and trace elements (Joule et al., 1995; Rout
et al., 1996; Thakur et al., 1997; Zhu et al., 2006). Thus need
to develop efﬁcient routes to synthesis biheterocycles is very
signiﬁcant.
The 2-aminothiazoles occur widely in structures of pharma-
ceutical interest together with many natural products
(Katritzky et al., 2008) They are used as intermediates in the
synthesis of antibacterial, antifungal (Bakr et al., 2012;
Gaurav et al., 2006; Ranjana et al., 2011) anticancer (Mei-Jung
Lai et al., 2011) and anti-inﬂammatory activities (Hans, 1977;
Wilson et al., 2001; Sharma et al., 1998). Synthetic thiazoles
have also been shown a wide variety of biological activity such
as antitumour activity (Shao et al., 2006), analgesic
(Basavaraja et al., 2008), antimicrobial (Mostafa and Abd
El-Salam, 2013; Sharshira and Hamada, 2012), anticonvulsant
(Azam et al., 2009), antihelminthic and insecticidal activity
(Himaja et al., 2012) as well as applications in liquid crystals
and cosmetic sunscreens (Karam et al., 2013). Pyrazoles are
another potent moiety that exhibit wide range of pharmaco-
logical activities such as antitumour (Nassar, 2010), antimicro-
bial (Sharshira and Hamada, 2011), anti-inﬂammatory (Haufel.doi.org/
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sive (Dmytro et al., 2009). So it is very important to synthesize
new compounds having both 2-aminothiazole and pyrazole
moieties. In this paper we are describing the synthesis of pyr-
azol-3ylthiazoles using 2-aminothiazoles as precursors. For
the pyrazole ring construction among the various methods
reported (Gupton et al., 2002; Panda and Jena, 2012; Yahia
et al., 2011) we have adopted the Vilsmeier Haack reaction.
In this method the hydrazone formed by the reaction of methyl
ketone and hydrazine was treated with Vilsmeier Haack com-
plex obtained by the reaction of DMF and phosphorous oxy-
chloride. This method is more advantageous than other
methods and the pyrazole ring construction has been achieved
in a single step with good yields.
2. Materials and method
IR spectra were recorded in KBr on FT-IR (Research Spectro-
photometer Series) and Perkin–Elmer FT-IR (Spectrum 1000).
1H NMR and 13C NMR spectra recorded on a Bruker AMX
(400 MHz) Spectrophotometer using DMSO-d6, CDCl3 and
CD3OD as solvent. TMS is used as internal standard (chemical
shifts in d) and mass spectra were recorded on a LC–MS
instrument. Compounds were checked for their purity by
TLC on silica gel G plates and spots were located by UV,
iodine vapor and DNP.
2.1. Synthesis of 1-[4-phenyl-2-(phenylamino)-1,3-thiazol-5-
yl]ethanone (1)
To the well stirred solution of the N-(phenylcarbamothioyl)
benzene carboximidamide (1.0 eq) in methanol and triethyl-
amine (1.5 eq), chloroacetone (1.2 eq) was added and stirred
at reﬂux for overnight. The progress of the reaction was mon-
itored using TLC. On completion of the reaction, the reaction
mixture was concentrated to remove methanol and extracted
over ethyl acetate and washed with water and dried over
sodium sulfate and solvent was recovered in vacuo, and the
crude mixture was puriﬁed over the column to get compound
1 with 85% yield as a yellow solid, 1H NMR (DMSO-d6,
400 MHz) d (ppm): 1.93(s, 3H, CH3), 7.01–7.62 (m, 10H, Ar)
10.8 (s, 1H, NH); MS: (M+), m/z 294.
2.2. Synthesis of N-substituted-1-[4-phenyl-2-(phenylamino)-
1,3-thiazol-5-yl]ethanone (2a–c)
2.2.1. General procedure
To the well stirred solution of compound 1(1.0 eq) in methanol
potassium carbonate (1.5 eq) was added followed by alkyl or
benzyl halide (1.2 eq) and the reaction mixture was reﬂuxed
for 3 h. On completion of the reaction, the reaction mixture
was concentrated to remove the methanol and extracted over
ethyl acetate and washed with water and dried over sodium
sulfate. The solvent was recovered in vacuo, and the formation
of compound was conﬁrmed by NMR and LC–MS.
2.2.1. 1-{2-[N-methyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-
yl}ethanone (2a)
Yellow solid, yield 510 mg (97%). 1H NMR (CD3OD,
400 MHz, d): 1.93 (s, 3H, CH3), 3.5 (s, 3H, CH3), 7.4–7.56
(m, 10H, Ar); MS: (M+), m/z 308.Please cite this article in press as: Yuvaraj, S., Manju, S.L. Design and synthesis of no
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yl}ethanone (2b)
Yellow solid, yield 520 mg (97%). 1H NMR (CDCl3,
400 MHz, d): 1.26 (t, 3H, CH3), 1.96 (s, 3H, CH3), 4.07 (q,
2H, CH2), 7.27–7.57 (m, 10H, Ar); MS: (M+), m/z 322.
2.2.3. 1-{2-[Benzyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-
yl}ethanone (2c)
Yellow solid, yield 600 mg (95%). 1H NMR (CDCl3,
400 MHz, d): 2.03 (s, 3H, CH3), 5.22 (s, 2H, CH2), 7.24–7.60
(m, 15H, Ar); MS: (M+), m/z 371.
2.3. Synthesis of N-substituted N-phenyl-5-[(1E)-1-(2-
substituted hydrazinylidene)ethyl]-1,3-thiazol-2-amine (3a–3l)
2.3.1. General procedure
To the well stirred solution of 2a–c (1.0 eq) in ethanol were
added hydrazine (1.0 eq) and catalytic amount of the acetic
acid and kept at reﬂux for 3 h. The reaction was monitored
by TLC. On completion of the reaction, the reaction mixture
was concentrated under vacuo to remove ethanol and the
crude mixture was taken as such for the next step. Some
compounds were puriﬁed and conﬁrmed by NMR and
LC–MS and others 3b, 3g, 3h, and 3l were conﬁrmed by
TLC and taken as such for next step without further
puriﬁcation.
2.3.1. N-Methyl-N,4-diphenyl-5-[(1E)-1-(2-
phenylhydrazinylidene)ethyl]-1,3-thiazol-2-amine (3a)
Yellow solid, yield 245 mg (95%). 1H NMR (DMSO-d6,
400 MHz, d): 1.76 (s, 3H, CH3), 3.3 (s, 3H, CH3), 6.69–7.5
(m, 15H, Ar), 9.11 (s, 1H, NH); MS: (M+), m/z 398. Anal.
calcd. for C24H22N4S (398.52): C, 72.33; H, 5.56; N, 14.06%.
Found: C, 72.29; H, 5.61; N, 14.01%.
2.3.2. N-Methyl-N,4-diphenyl-5-[(1E)-1-(2-(4-
Chlorophenyl)hydrazinylidene)ethyl]-1,3-thiazol-2-amine (3c)
Yellow solid, yield 260 mg (93%). 1H NMR (DMSO-d6,
400 MHz, d): 1.76 (s, 3H, CH3), 3.5 (s, 3H, CH3), 6.98–7.54
(m, 14H, Ar), 9.2 (s, 1H, NH); MS: (M+), m/z 432. Anal.
calcd. for C24H21ClN4S (432.97): C, 66.58; H, 4.89; N,
12.94%. Found: C, 66.60; H, 4.85; N, 12.90%.
2.3.3. N-methyl-N,4-diphenyl-5-[(1E)-1-(2-(2-methyl
phenyl)hydrazinylidene)ethyl]-1,3-thiazol-2-amine (3d)
Yellow solid, yield 240 mg (90%). 1H NMR (DMSO-d6,
400 MHz, d): 1.84 (s, 3H, CH3), 2.1 (s, 3H, CH3) 3.48 (s,
3H, CH3), 6.68–7.54 (m, 14H, Ar), 7.8 (s, 1H, NH); MS:
(M+), m/z 412. Anal. calcd. for C25H24N4S (412.55): C,
72.78; H, 5.86; N, 13.58%. Found: C, 72.70; H, 5.79; N,
13.52% .
2.3.4. N-Ethyl-N,4-diphenyl-5-[(1E)-1-(2-
phenylhydrazinylidene)ethyl]-1,3-thiazol-2-amine (3e)
Yellow solid, yield 243 mg (95%). 1H NMR (DMSO-d6,
400 MHz, d): 1.18 (t, 3H, CH3), 1.76 (s, 3H, CH3), 3.99 (q,
2H, CH2) 6.69–7.5 (m, 15H, Ar), 9.11 (s, 1H, NH); MS:
(M+), m/z 412. Anal. calcd. for C25H24N4S (412.55): C,
72.78; H, 5.86; N, 13.58%. Found: C, 72.80; H, 5.82; N,
13.61%.vel pyrazol-3ylthiazoles. Arabian Journal of Chemistry (2014), http://dx.doi.org/
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phenyl)hydrazinylidene)ethyl]-1,3-thiazol-2-amine (3f)
Yellow solid, yield 253 mg (95%). 1H NMR (DMSO-d6,
400 MHz) d: 1.18 (t, 3H, CH3), 1.76 (s, 3H, CH3), 3.99
(q, 2H, CH2) 6.97–7.9 (m, 14H, Ar), 9.08 (s, 1H, NH); MS:
(M+), m/z 430. Anal. calcd. for C25H23FN4S (430.54):
C, 69.74; H, 5.38; N, 13.01%. Found: C, 69.79; H, 5.32;
N, 13.05%.
2.3.6. N-Benzyl-N,4-diphenyl-5-[(1E)-1-(2-
phenylhydrazinylidene)ethyl]-1,3-thiazol-2-amine (3i)
Yellow solid, yield 242 mg (92%). 1H NMR (DMSO-d6,
400 MHz, d): 1.78 (s, 3H, CH3), 5.2 (s, 2H, CH2), 6.68–
7.51 m, 20H, Ar), 9.11 (s, 1H, NH); MS: (M+), m/z 474. Anal.
calcd. for C30H26N4S (474.62): C, 75.92; H, 5.52; N, 11.80%.
Found: C, 75.89; H, 5.55; N, 11.87%.
2.3.7. N-Benzyl-N,4-diphenyl-5-[(1E)-1-(2(4-
ﬂuorophenyl)hydrazinylidene)ethyl]-1,3-thiazol-2-amine (3j)
Yellow solid, yield 249 mg (93%). 1H NMR (DMSO-d6,
400 MHz, d): 1.78 (s, 3H, CH3), 5.2 (s, 2H, CH2), 6.69–7.51
(m, 19H, Ar), 9.11 (s, 1H, NH); MS: (M+), m/z 492. Anal.
calcd. for C30H25FN4S (492.61): C, 73.15; H, 5.12; N,
11.37%. Found: C, 73.19; H, 5.10; N, 11.31%.
2.3.8. N-Benzyl-N,4-diphenyl-5-[(1E)-1-(2(4-chloro
phenyl)hydrazinylidene)ethyl]-1,3-thiazol-2-amine (3k)
Yellow solid, yield 259 mg (93%). 1H NMR (DMSO-d6,
400 MHz, d): 1.79 (s, 3H, CH3), 5.2 (s, 2H, CH2), 6.98–7.52
(m, 19H, Ar), 9.26 (s, 1H, NH); MS: (M+), m/z 508. Anal.
calcd. for C30H25ClN4S (509.06): C, 70.78; H, 4.95; N,
11.01%. Found: C, 70.72; H, 5.01; N, 11.08%.
2.4. Synthesis of 3-{substituted 1,3-thiazol-5-yl}-1-substituted
1H-pyrazole-4-carbaldehyde (4a–l)
2.4.1. General procedure
To the cooled solution of DMF (8.0 eq) at 0 C was added
POCl3 (3.0 eq) dropwise and stirred at same temperature for
another 1 h to form Vilsmeier reagent. Then the compound
3a–l (1.0 eq) was taken in DMF and added drop wise to the
reaction mixture for half an hour and stirred at 0 C for 1 h
and then heated at 80 C for 6 h. Then the reaction mixture
was quenched with ice and neutralized with sodium bicarbon-
ate. The resultant solution was then extracted with ethyl ace-
tate, washed with water and dried over sodium sulfate. The
solvent was recovered in vacuo and puriﬁed over column chro-
matography. The compound isolated was conﬁrmed by 1H
NMR, 13C NMR, mass spectrum and IR spectrum.
2.4.1. 3-{2-[Methyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-
1-phenyl-1H-pyrazole-4-carbaldehyde (4a)
Yellow solid, yield 164 mg (75%), m.p. 168–169 C.
IR (KBr, cm1): 1677(C‚O). 1H NMR (CDCl3, 400 MHz,
d): 3.6 (s, 3H, CH3), 7.2–7.7 (m, 15H, Ar) 8.3 (s, 1H, Ar), 9.2
(s, 1H, CHO). 13C NMR (CDCl3, d): 119.5, 122.03, 125.32,
127.07, 127.89, 128.52, 128.64, 128.83, 129.41, 129.63, 129.96,
138.81, MS: (M+), m/z 437. Anal. calcd. for C25H20N4OS
(436.53): C, 71.54; H, 4.62; N, 12.83%. Found: C, 71.50; H,
4.66; N, 12.79%.Please cite this article in press as: Yuvaraj, S., Manju, S.L. Design and synthesis of no
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1-(4-ﬂuorophenyl)-1H-pyrazole-4-carbaldehyde (4b)
Yellow solid, yield 159 mg (73%), m.p. 173–174 C.
IR (KBr, cm1): 1677 (C‚O). 1H NMR (CDCl3,
400 MHz, d: 3.66 (s, 3H, CH3), 7.15–7.68 (m, 14H, Ar), 8.3
(s, 1H, Ar) 9.18 (s, 1H, CHO). 13C NMR (CDCl3, d):
40.15, 116.45, 116.68, 121.35, 121.43, 122.05, 122.34, 127.14,
128.58, 128.69, 128.82, 129.48, 129.99, 145.96, 185.19. MS:
(M+), m/z 455. Anal. calcd. for C26H19FN4OS (454.52): C,
68.71; H, 4.21; N, 12.33%. Found: C, 68.75; H, 4.25; N,
12.38%.
2.4.3. 3-{2-[Methyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-
1-(4-chlorophenyl)-1H-pyrazole-4-carbaldehyde (4c)
Yellow solid, yield 159 mg (75%), m.p. 182–183 C.
IR (KBr, cm1): 1677(C‚O). 1H NMR (CDCl3, 400 MHz,
d: 3.67 (s, 3H, CH3), 7.27–7.66 (m, 14H, Ar), 8.3 (s, 1H,
Ar).9.18 (s, 1H, CHO). 13C NMR (CDCl3, d: 40.06, 109.13,
120.61, 122.26, 125.33, 127.07, 128.53, 128.66, 128.80, 129.32,
129.75, 129.96, 133.53, 134.65, 137.34, 146.01, 147.74, 150.72,
169.30, 185.07. MS: (M+), m/z 471. Anal. calcd. for C26H19-
ClN4OS (470.97): C, 66.30; H, 4.07; N, 11.90%. Found: C,
66.36; H, 4.11; N, 11.95%.
2.4.4. 3-{2-[Methyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-
1-(2-methylphenyl)-1H-pyrazole-4-carbaldehyde (4d)
Yellow solid, yield 164 mg (70%), m.p. 143–144 C.
IR (KBr, cm1): 1677 (C‚O). 1H NMR (CDCl3,
400 MHz, d: 2.25 (s, 3H, CH3), 3.65 (s, 3H, CH3) 7.27–7.66
(m, 14H, Ar), 8.04 (s, 1H, Ar) 9.18 (s, 1H, CHO). 13C NMR
(CDCl3, d: 18.08, 40.21, 109.28, 121.2, 125.2, 125.83, 127.08,
128.45, 128.62, 128.82, 129.44, 129.97, 131.52, 133.49, 133.61,
138.62, 145.96, 169.22, 185.31. MS: (M+), m/z 451. Anal.
calcd. for C27H22N4OS (450.55): C, 71.98; H, 4.92; N,
12.44%. Found: C, 71.89; H, 4.88; N, 12.40%.
2.4.5. 3-{2-[Ethyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-1-
phenyl-1H-pyrazole-4-carbaldehyde (4e)
Yellow solid, yield 164 mg (70%), m.p. 171–172 C. IR (KBr,
cm1): 1676 (C‚O). 1H NMR (CDCl3, 400 MHz, d: 1.34 (t,
3H, CH3), 4.1 (q, 2H, CH2), 7.2–7.7 (m, 15H, Ar), 8.36 (s,
1H, Ar), 9.21 (s, 1H, CHO). 13C NMR (CDCl3, d: 13.25,
47.4, 108.91, 119.48, 121.95, 127.35, 127.74, 127.85, 128.42,
128.62, 128.81, 129.34, 129.62, 130.13, 138.81, 144.40, 147.71,
169.25, 185.40. MS: (M+), m/z 451. Anal. calcd. for C27H22N4-
OS (450.55): C, 71.98; H, 4.92; N, 12.44%. Found: C, 71.91; H,
4.89; N, 12.49% .
2.4.6. 3-{2-[Ethyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-1-
(4-ﬂuorophenyl)-1H-pyrazole-4-carbaldehyde (4f)
Yellow solid, yield 165 mg (73%), m.p. 185–186 C.
IR (KBr, cm1): 1676 (C‚O). 1H NMR (CDCl3,
400 MHz, d: 1.33 (t, 3H, CH3), 4.1 (q, 2H, CH2), 7.14–
7.68(m, 14H, Ar), 8.2 (s, 1H, Ar), 9.19 (s, 1H, CHO). 13C
NMR (CDCl3, d: 13.17, 47.43, 108.67, 116.34, 116.57,
121.25, 1 21.33, 121.95, 127.27, 127.76, 128.45, 128.56,
128.76, 129.34, 130.09, 135.08, 144.24, 163.03, 169.21, 185.18.
MS: (M+), m/z 469. Anal. calcd. for C27H21FN4OS (468.55):
C, 69.21; H, 4.52; N, 11.96%. Found: C, 69.28; H, 4.57; N,
11.90% .vel pyrazol-3ylthiazoles. Arabian Journal of Chemistry (2014), http://dx.doi.org/
4 S. Yuvaraj, S.L. Manju2.4.7. 3-{2-[Ethyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-1-
(4-chlorophenyl)-1H-pyrazole-4-carbaldehyde (4g)
Yellow solid, yield 165 mg (76%), m.p. 200–201 C.
IR (KBr, cm1): 1677 (C‚O). 1H NMR (CDCl3,
400 MHz, d: 1.33 (t, 3H, CH3) 4.14 (q, 2H, CH2), 7.27–7.65
(m, 14H, Ar), 8.32 (s, 1H, Ar), 9.19 (s, 1H, CHO). 13C
NMR (CDCl3, d: 13.24, 47.48, 120.59, 122.14, 127.37,
127.86, 128.55, 128.83, 129.30, 129.75, 130.18, 133.49, 137.31,
144.32, 169.33, 185.24. MS: (M+), m/z 485. Anal. calcd. for
C27H21ClN4OS (485): C, 66.86; H, 4.36; N, 11.55%. Found:
C, 66.80; H, 4.40; N, 11.50%.
2.4.8. 3-{2-[Ethyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-1-
(2-methylphenyl)-1H-pyrazole-4-carbaldehyde (4h)
Yellow solid, yield 157 mg (72%), m.p. 145–146 C.
IR (KBr, cm1): 1677 (C‚O). 1H NMR (CDCl3,
400 MHz, d: 1.33 (t, 3H, CH3), 2.24(s, 3H, CH3), 4.15(q, 2H,
CH2), 7.27–7.66 (m, 14H, Ar), 8.03 (s, 1H, Ar), 9.28 (s, 1H,
CHO), 13C NMR (CDCl3, d: 13.17, 18.01, 121.15, 125.76,
126.75, 127.23, 127.65, 128.74, 129.33, 130.05, 131.43, 133.45,
138.58, 185.36. MS: (M+), m/z 465. Anal. calcd. for C28H24N4
OS (464.58): C, 72.39; H, 5.21; N, 12.06%. Found: C, 72.41; H,
5.28; N, 12.11%.
2.4.9. 3-{2-[Benzyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-
1-phenyl-1H-pyrazole-4-carbaldehyde (4i)
Yellow solid, yield 162 mg (75%), m.p. 142–143 C. IR (KBr,
cm1): 1681 (C‚O) cm1. 1H NMR (CDCl3, 400 MHz, d):
5.31 (s, 2H, CH2), 7.27–7.70 (m, 20H, Ar), 8.37 (s, 1H, Ar),
9.20 (s, 1H, CHO), 13C NMR (CDCl3, d): 56.18, 109.29,
116.44, 116.67, 121.33, 121.43, 122.04, 127.07, 127.50, 127.79,
128.46, 128.59, 128.64, 129.50, 130.07, 134.42, 135.09, 137.36,
144.43, 147.57, 150.17, 169.56, 185.23. MS: (M+), m/z 513.
Anal. calcd. for C32H24N4OS (512.62): C, 74.98; H, 4.72; N,
10.93%. Found: C, 74.93; H, 4.69; N, 10.97%.
2.4.10. 3-{2-[Benzyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-
1-(4-ﬂuorophenyl)-1H-pyrazole-4-carbaldehyde (4j)
Yellow solid, yield 157 mg (73%), m.p. 156–157 C. IR (KBr,
cm1): 1677 (C‚O) cm1. 1H NMR (CDCl3, 400 MHz, d):
5.31 (s, 2H, CH2), 7.16–7.67 (m, 19H, Ar), 8.30 (s, 1H, Ar),S
N
H
N
H3C
O
H3C
S
N
R
N
H3C
N
NH
R2
POCl3, DMF
R1-X
Vilsmeier reaction
1
3
Scheme 1 General synthetic pathways for the preparation of synthe
carbaldehyde.
Please cite this article in press as: Yuvaraj, S., Manju, S.L. Design and synthesis of no
10.1016/j.arabjc.2014.10.0059.20 (s, 1H, CHO), 13C NMR (CDCl3, d): 56.18, 109.29,
116.44, 116.67, 121.33, 121.43, 122.04, 127.07, 127.50, 127.79,
128.46, 128.59, 128.64, 129.50, 130.07, 134.42, 135.09, 137.36,
144.43, 147.57, 150.17, 169.56, 185.23, MS: (M+), m/z 532.
Anal. calcd. For C32H23FN4OS (530.61): C, 72.43; H, 4.37;
N, 10.56%. Found: C, 72.39; H, 4.30; N, 10.59%.
2.4.11. 3-{2-[Benzyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-
1-(4-chlorophenyl)-1H-pyrazole-4-carbaldehyde (4k)
Yellow solid, yield 154 mg (72%), m.p. 184–185 C. IR (KBr,
cm1): 1677 (C‚O) cm1. 1H NMR (CDCl3, 400 MHz) d
(ppm): 5.31 (s, 2H, CH2), 7.26–7.65 (m, 19H, Ar), 8.33 (s,
1H, Ar), 9.19 (s, 1H, CHO). 13C NMR (CDCl3 d): 56.29,
109.23, 120.59, 122.17, 127.08, 127.52, 127.85, 128.47, 128.50,
128.66, 128.85, 129.39, 129.77, 130.10, 133.55, 134.32, 137.27,
137.31, 144.39, 147.62, 169.61, 185.14. MS: (M+), m/z 547.
Anal. calcd. for C32H23ClN4OS (547.07): C, 70.25; H, 4.24;
N, 10.24%. Found: C, 70.19; H, 4.20; N, 10.19%.
2.4.12. 3-{2-[Benzyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-
1-(2-methylphenyl)-1H-pyrazole-4-carbaldehyde (4l)
Yellow solid, yield 162 mg (75%), m.p. 139–141 C. IR (KBr,
cm1): 1677 (C‚O) cm1. 1H NMR (CDCl3, 400 MHz, d):
2.24 (s, 2H, CH3), 5.30 (s, 2H, CH2), 7.26–7.66 (m, 19H,
Ar), 8.04 (s, 1H, Ar), 9.3 (s, 1H, CHO). 13C NMR (CDCl3,
d): 18.03, 56.13, 109.40, 121.35, 125.82, 126.81, 126.95,
127.40, 127.55, 128.30, 128.40, 128.42, 128.51, 128.76, 129.36,
129.96, 131.49, 133.47, 133.53, 134.78, 137.55, 138.66, 144.58,
147.11, 150.18, 169.42, 185.34. MS: (M+), m/z 527. Anal.
calcd. For C33H26N4OS (526.65): C, 75.26; H, 4.98; N,
10.64%. Found: C, 75.29; H, 4.91; N, 10.69%.
3. Results and discussion
The starting material, 2-aminothiazoles has been synthesized
by reported methods. Among the various synthetic methods
used for the construction of the 1,3-thiazole rings
(Ruettinger, 1976; Ortega et al., 2000), the strategy involving
benzamidine and phenylisothiocyanate as starting material
(Murawewa, 1959) was adopted in the present investigation.
The treatment of the benzamidine and phenylisothiocyanateS
N
R1
N
O
Ethanol, reflux,3 hr
N
H
NH2R2
S
N
R1
N
N
N
O
R2
2
4
R1 =alkyl and aryl
R2 = alkyl
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Table 1 Synthesis of 3-{substituted 1,3-thiazol-5-yl}-1-substi-
tuted 1H-pyrazole-4-carbaldehydes.
Entry Compound R1 R2 Yield (%)
1 4a CH3 C6H5 75
2 4b CH3 4-F-C6H5 73
3 4c CH3 4-Cl-C6H5 75
4 4d CH3 2-CH3-C6H5 70
5 4e C2H5 C6H5 70
6 4f C2H5 4-F-C6H5 73
7 4g C2H5 4-Cl-C6H5 76
8 4h C2H5 2-CH3-C6H5 72
9 4i C6H5CH2 C6H5 75
10 4j C6H5CH2 4-F-C6H5 73
11 4k C6H5CH2 4-Cl-C6H5 72
12 4l C6H5CH2 2-CH3-C6H5 75
Design and synthesis of novel pyrazol-3ylthiazoles 5with diisopropylethylamine in DMF yielded N-(phen-
ylcarbamothioyl)benzene carboximidamide. This on treatment
with chloroacetone and triethylamine in methanol yielded a
mixture of [2-(N-benzyl-N-ethylamino)-4-methylthiazol-5-
yl)(phenyl)methanone (major product) and 1-[2-(N-benzyl-N-
ethylamino-4-phenylthiazol-5-yl)ethanone 1 (minor product),
the isolation of the two products was difﬁcult since both have
same Rf value (TLC). The mixture was then treated with alkyl
halides with potassium carbonate as base in methanol at reﬂux
conditions to yield N-substituted-1-[4-phenyl-2-(phenylami-
no)-1,3-thiazol-5-yl]ethanone 2a–c. This was then treated with
different hydrazines. The minor compound only reacted with
hydrazine and converted to hydrazones 3a–l. Among these
compounds, 3b, 3g, 3h, and 3l were highly unstable at room
temperature and they were taken directly into the next step
without further puriﬁcation Scheme 1. All other compounds
were column chromatographed and were conﬁrmed by spectral
studies. The hydrazone 3a treated with phosphorous oxychlo-
ride in DMF under Vilsmeier–Haack condition (Meth-Cohn
and Stanforth, 1991) afforded a yellow compound 4a which
was puriﬁed through column chromatography. The appear-
ance of the band at 1680.8 cm1 in the IR spectrum of the
compound 4a indicated the presence of a carbonyl group.
The NMR spectrum showed a singlet at around d 8.3 ppm cor-
responding to the pyrazole ring which conﬁrmed the cycliza-
tion and also disappearance of the methyl proton at around
d 1.9 ppm was observed. The formation of the compound
was then conﬁrmed by the mass spectral analysis. It exhibited
a molecular ion peak at m/z 436 corresponding to its molecular
weight. Thus the compound obtained has been conﬁrmed as 3-
{2-[methyl(phenyl)amino]-4-phenyl-1,3-thiazol-5-yl}-1-phenyl-
1H-pyrazole-4 carbaldehyde. Similarly all the other derivatives
were synthesized, column chromatographed and characterized
by spectroscopic studies. The yields of the compounds are
found to be the same irrespective of the substituent at the
R2 position (Table 1).
4. Conclusions
In summary we have described an efﬁcient synthetic route to
obtain novel pyrazol-3ylthiazoles starting from 2-aminothiaz-
oles. The generality of the method has been demonstrated by
synthesizing 12 derivatives.Please cite this article in press as: Yuvaraj, S., Manju, S.L. Design and synthesis of no
10.1016/j.arabjc.2014.10.005References
Azam, F., Ikskas, I.A., Khokra, S.L., Prakash, O., 2009. Eur. J. Med.
Chem. 44, 203–211.
Basavaraja, K.M., Somasekhar, B., Appalaraju, S., 2008. Ind. J.
Heterocycl. Chem. 18, 69–72.
Bakr, F., Abdel-Wahab, Ehab Abdel-Latif, Hanan, A., Mohamed,
Ghada, E.A., Awad, 2012. Eur. J. Med. Chem. 52, 263–268.
Dmytro, H., Borys, Z., Olexandr, V., Lucjusz, Z., Andrzej, G.,
Roman, L., 2009. Eur. J. Med. Chem. 44, 1396–1404.
Gaurav, G., Suvarna, G., Kini, 2006. Eur. J. Med. Chem. 41, 256–262.
Gupton, T., Clough, C., Miller, B., Norwood, K., Hickenboth, R.,
Chertudi, Itta Bluhn, Cutro, R., Petrich, A., Hicks, A., Wilkinson,
R., Sikorski, A., 2002. Tetrahedron 58, 5467–5474.
Hans, N.; Swiss Patent 592103, 1977, 1978. Chem. Abstr. 88, 22886.
Haufel, J., Breitmaier, E., 1974. Angew. Chem. 13, 604.
Himaja, M., Gupta, N., Munirajashekhar, D., Karigar, A., Sikarwar,
M.K., 2012. J. Pharm. Sci. Innov. 14, 33–36.
Joule, J.A., Nills, K., Smith, G.F., 1995. Heterocyclic Chemistry, 3rd
edn. Chapman and Hall, London.
Karam, H., Tomma, H., Al-Dujaili, H., 2013. Chem. Mater. Res. 3,
162–171.
Katritzky, A.R., Ramsden, C.A., Scriven, E.F.V., Taylor, R.J.K.
(Eds.), 2008. Comprehensive Heterocyclic Chemistry. Elsevier: Inc.,
Oxford, pp. 635–754, Vol. 4.
Lai, Mei-Jung, Chang, Jang -Yang, Lee, Hsueh -Yun, Kuo, Ching -
Chuan, Lin, Mei -Hsiang, Hsieh, Hsing -Pang, Chang, Chi -Yen,
Jian-Sung, Wu, Su-Ying, Wu, Shey, Kuang-Shing, Liou, Jing-Ping,
2011. Eur. J. Med. Chem. 46, 3623–3629.
Meth-Cohn, O., Stanforth, S.P., 1991. Comp. Org. Synth. 2, 777–794.
Mostafa, M.S., Abd El-Salam, N.M., 2013. Der. Pharm. Chem. 5, 1–7.
Murawewa, D.A.N.K.A.S., 1959. Dokl. Akad. Nauk SSSR 126, 1274.
Nassar, E., 2010. J. Am. Sci 6, 463–471.
Panda, Niranjan., Jena, Ashis Kumar, 2012. J. Org. Chem. 77, 9401–
9406.
Noack, A., Schroder, A., Hartmann, H., 2002. Dyes Pigm. 57, 131.
Ortega, R., Aviles, A., Cruz, A., Go´mez, R., Plata, A., 2000. J. Org.
Chem. 65, 7244.
Park, J.W., Lee, J.H., Kha, S.I., Kim, T.W., 2001. Curr. Appl. Phys. 1,
125.
Ranjana, A., Rajiv, K., Sunil, K., Gaurav, G., Ritu, M., Jitender, S.,
2011. J. Fluorine Chem. 132, 965–972.
Rout, K.C., Mohanty, R.R., Jena, S., Dash, K.C., 1996. Polyhedron
15, 1023.
Ruettinger, PHARAT; 1976. Pharmazie: German, 31, 218.
Shao, L., Zhou, X., Hu, Y., Jin, Z., Liu, J., Fang, J.X., 2006. Metal-
Org. Nano-Metal Chem. 36, 325–330.
Sharma, P.K., Swonhney, S.N., Gupta, A., Singh, G.B., Bani, S., 1998.
Indian J. Chem. 37B, 371.
Sharshira, E.M., Hamada, N.M.M., 2011. Molecules 16, 2304–2312.
Sharshira, E.M., Hamada, N.M.M., 2012. Am. J. Org. Chem. 2, 69–
73.
Thakur, P., Chakarvortty, V., Dash, K.C., 1997. Polyhedron 16, 1417.
Wilson, K.J., Utig, C.R., Subhasinghe, N., Hoffman, J.B., Rudolph,
N.J., Soll, R., Molloy, C.J., Bone, R., Green, D., Randall, J., 2001.
Bioorg. Med. Chem. Lett. 11, 915.
Wright, D., Usher, L., 2001. Curr. Org. chem. 5, 1107.
Yahia, Nasser Mabkhot, Abdullah, Mohammad Al-Majid, Alamary,
S., 2011. Molecules 16, 7706–7714.
Zhai Xin, Zhao Yan Fang, Wang Jia, Hong Wei, Huang Liang, Gong
Ping, 2006. Chem. Res. Chin. 22 (4), 4594.
Zhang, Z.Y., Chen, X., Wei, L.L., Ma, Z.L., 1991. Chem. Res. Chin.
Univ. 2, 129.
Zhu, X., Zhang, Y.M., Li, B.L., Zhang, Y., 2006. J. Coord. Chem. 59,
513.vel pyrazol-3ylthiazoles. Arabian Journal of Chemistry (2014), http://dx.doi.org/
